Search

everythinglearnresearchcommunity

for

Search:↓

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

Acneiform follicular mucinosis can be controlled with systemic corticosteroids.

Mammograms are important for detecting breast cancer early.

M1 homeopathic complex may help slow melanoma cell growth.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

A 16-year-old boy's facial condition improved with doxycycline, suggesting an immune response to hair follicle damage.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Multiparametric ultrasound is a useful non-invasive tool for assessing scalp conditions in alopecia areata patients.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Mnemonics help remember dermatology information.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

The new skin model can predict how chemicals might cause skin allergies.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Mogamulizumab can cause hair loss and skin rashes.

Microneedle Therapy System effectively treats acne, scars, and hair loss safely.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

A rare form of lupus caused hair loss and skin bumps, diagnosed through biopsy, improved partially with treatment.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Men with systemic lupus erythematosus often have more severe symptoms but can respond well to treatment.

MFN2 mutations cause mitochondrial problems, leading to more upper body fat and lower leptin levels.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.